Create
Log in
Enquire now
Extended Delivery of Bupivacaine Study in Herniorrhaphy
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Clinical study
0
Allocation Type
Randomized
0
Health Conditions in Trial
Analgesia
0
Intervention Model
Parallel Assignment
0
Intervention Name
Bupivacaine liposome injectable suspension
0
Bupivacaine HCl without epinephrine via continuous infusion
0
Interventional Trial Phase
Phase 4
0
Interventional Trial Purpose
Prevention
0
Intervention Type
Drug
0
Last Updated
September 26, 2019
0
Masking Type
None (Open Label)
0
Primary Completion Date
September 3, 2018
0
Trial Recruitment Size
32
0
Trial Sponsor
Heron Therapeutics
0
Clinical Trial Start Date
July 2, 2018
0
Study Completion Date
October 26, 2018
0
Clinical Trial Study Type
Interventional
0
NCT Number
NCT04102267
0
Official Name
A Randomized, Phase 4 Study of the Efficacy, Safety, and Pharmacokinetics of Bupivacaine Administered as Liposomal Bupivacaine or Continuous Infusion Via Elastomeric Pump Following Unilateral Open Inguinal Herniorrhaphy
0
Official Website
clinicaltrials.gov/study...102267
0
Find more entities like Extended Delivery of Bupivacaine Study in Herniorrhaphy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE